BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 31331757)

  • 1. Intraperitoneal Cefepime Monotherapy Versus Combination Therapy of Cefazolin Plus Ceftazidime for Empirical Treatment of CAPD-Associated Peritonitis: A Multicenter, Open-Label, Noninferiority, Randomized, Controlled Trial.
    Kitrungphaiboon T; Puapatanakul P; Chuengsaman P; Tiskajornsiri K; Halue G; Siribamrungwong M; Matayart S; Chongthanakorn K; Poonvivatchaikarn U; Boonyakrai C; Somboonsilp W; Katavetin P; Praditpornsilpa K; Eiam-Ong S; Johnson DW; Kanjanabuch T
    Am J Kidney Dis; 2019 Nov; 74(5):601-609. PubMed ID: 31331757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function.
    Lui SL; Cheng SW; Ng F; Ng SY; Wan KM; Yip T; Tse KC; Lam MF; Lai KN; Lo WK
    Kidney Int; 2005 Nov; 68(5):2375-80. PubMed ID: 16221243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis--a randomized controlled trial.
    Leung CB; Szeto CC; Chow KM; Kwan BC; Wang AY; Lui SF; Li PK
    Perit Dial Int; 2004; 24(5):440-6. PubMed ID: 15490983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal Vancomycin Plus Either Oral Moxifloxacin or Intraperitoneal Ceftazidime for the Treatment of Peritoneal Dialysis-Related Peritonitis: A Randomized Controlled Pilot Study.
    Xu R; Yang Z; Qu Z; Wang H; Tian X; Johnson DW; Dong J
    Am J Kidney Dis; 2017 Jul; 70(1):30-37. PubMed ID: 28027794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
    Peerapornratana S; Chariyavilaskul P; Kanjanabuch T; Praditpornsilpa K; Eiam-Ong S; Katavetin P
    Perit Dial Int; 2017; 37(2):218-224. PubMed ID: 27738089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis.
    Wong KM; Chan YH; Cheung CY; Chak WL; Choi KS; Leung SH; Leung J; Chau KF; Tsang DN; Li CS
    Am J Kidney Dis; 2001 Jul; 38(1):127-31. PubMed ID: 11431192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Gucek A; Bren AF; Hergouth V; Lindic J
    Adv Perit Dial; 1997; 13():218-20. PubMed ID: 9360685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective treatment of peritoneal dialysis-associated peritonitis with cefazolin and ceftazidime in children.
    Rusthoven E; Monnens LA; Schröder CH
    Perit Dial Int; 2001; 21(4):386-9. PubMed ID: 11587402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD.
    Cheng IK; Fang GX; Chau PY; Chan TM; Tong KL; Wong AK; Li CS; Lo WK; Cheung KO; Kumana CR
    Perit Dial Int; 1998; 18(4):371-5. PubMed ID: 10505557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intraperitoneal cefazolin and gentamicin in empiric therapy of peritonitis in continuous ambulatory peritoneal dialysis patients.
    Tosukhowong T; Eiam-Ong S; Thamutok K; Wittayalertpanya S; Na Ayudhya DP
    Perit Dial Int; 2001; 21(6):587-94. PubMed ID: 11783768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. Members of APN Arbeitsgemeinschaft Paidiatrische Nephrologie.
    Klaus G; Schaefer F; Müller-Wiefel D; Mehls O
    Adv Perit Dial; 1995; 11():296-301. PubMed ID: 8534728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.
    Triyawatanyu P; Chariyavilaskul P; Phaisal W; Peerapornratana S; Kanjanabuch T; Praditpornsilpa K; Katavetin P
    Perit Dial Int; 2020 Mar; 40(2):179-184. PubMed ID: 32063189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment for peritoneal dialysis-associated peritonitis.
    Ballinger AE; Palmer SC; Wiggins KJ; Craig JC; Johnson DW; Cross NB; Strippoli GF
    Cochrane Database Syst Rev; 2014 Apr; (4):CD005284. PubMed ID: 24771351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic analysis of ceftazidime and cefazolin in the treatment of continuous ambulatory peritoneal dialysis-related peritonitis.
    Zhu W; Fang X; Zheng J; Ke Y; He Q; Cui T; Chen B; Tian L
    Ren Fail; 2023; 45(2):2285873. PubMed ID: 38044852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial intraperitoneal therapy for CAPD peritonitis: the Network 9 Peritonitis Study.
    Brier ME; Aronoff GR
    Adv Perit Dial; 1994; 10():141-3. PubMed ID: 7999812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin and ceftazidime in the treatment of CAPD peritonitis.
    Beaman M; Solaro L; McGonigle RJ; Michael J; Adu D
    Nephron; 1989; 51(1):51-5. PubMed ID: 2644565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ceftazidime in CAPD-related peritonitis.
    Booranalertpaisarn V; Eiam-Ong S; Wittayalertpanya S; Kanjanabutr T; Na Ayudhya DP
    Perit Dial Int; 2003; 23(6):574-9. PubMed ID: 14703199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal Antibiotic Utilization among Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients with Peritonitis at a Tertiary Hospital Setting in Malaysia.
    Ahmad M; Zin CS; Ab Rahman AF
    J Pharm Bioallied Sci; 2020 Nov; 12(Suppl 2):S737-S742. PubMed ID: 33828370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.
    Khairullah Q; Provenzano R; Tayeb J; Ahmad A; Balakrishnan R; Morrison L
    Perit Dial Int; 2002; 22(3):339-44. PubMed ID: 12227391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of CAPD peritonitis management and outcomes in North and South Thames NHS regions (U.K.): support for the ISPD guidelines. International Society for Peritoneal Dialysis.
    Kent JR; Almond MK
    Perit Dial Int; 2000; 20(3):301-5. PubMed ID: 10898047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.